143 related articles for article (PubMed ID: 8999764)
1. [Effect of contemporary chemotherapeutic drugs on phagocyte activity and the immune response].
Nikitin AV; Navashin PS; Smolkina TV
Antibiot Khimioter; 1996; 41(7-8):49-56. PubMed ID: 8999764
[No Abstract] [Full Text] [Related]
2. [Effect of fluoroquinolones on the interaction of phagocytic cells with pathogens, lymphocyte function and immune response].
Iordanova AI; Smolkina TV; Nikitin AV
Antibiot Khimioter; 1995 Aug; 40(8):50-6. PubMed ID: 8713440
[No Abstract] [Full Text] [Related]
3. Macrolides and the immune system.
McDonald PJ; Pruul H
Scand J Infect Dis Suppl; 1992; 83():34-40. PubMed ID: 1488627
[TBL] [Abstract][Full Text] [Related]
4. Treatment of infections caused by rapidly growing mycobacteria in the era of the newer macrolides.
Wallace RJ
Res Microbiol; 1996; 147(1-2):30-5. PubMed ID: 8761719
[No Abstract] [Full Text] [Related]
5. Community-acquired pneumonia.
Bartlett JG
Int J Clin Pract Suppl; 2000 Dec; (115):18-22. PubMed ID: 11219294
[No Abstract] [Full Text] [Related]
6. [Experimental evaluation of antibiotics as immunomodulators].
Labro MT
J Chemother; 1994 Aug; 6 Suppl 3():11-5. PubMed ID: 7861202
[TBL] [Abstract][Full Text] [Related]
7. [Current antimicrobial drugs].
van Kasteren ME; Natsch S; van der Meer JW
Ned Tijdschr Geneeskd; 1997 Dec; 141(49):2392-6. PubMed ID: 9554159
[TBL] [Abstract][Full Text] [Related]
8. [Macrolides and immunity].
Labro MT
Rev Med Interne; 1987; 8(5):519-25. PubMed ID: 3328251
[TBL] [Abstract][Full Text] [Related]
9. [The immunomodulatory and anti-inflammatory properties of different antimicrobial agents].
Guz K; Bugla-Płoskońska G
Postepy Hig Med Dosw (Online); 2007 Dec; 61():828-37. PubMed ID: 18097341
[TBL] [Abstract][Full Text] [Related]
10. Antibiotics and their interaction with the host defense system in vivo.
Grassi GG; Fietta A
J Chemother; 1991 Jan; 3 Suppl 1():112-5. PubMed ID: 12041742
[TBL] [Abstract][Full Text] [Related]
11. Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?
Labro MT
Clin Microbiol Rev; 2000 Oct; 13(4):615-50. PubMed ID: 11023961
[TBL] [Abstract][Full Text] [Related]
12. [Immunomodulators, their nature and immunotherapeutic effect].
Artsimovich NG
Gematol Transfuziol; 1988 Oct; 33(10):37-41. PubMed ID: 3063590
[No Abstract] [Full Text] [Related]
13. [New antibiotics in 1997: what is their value to the dermatologist?].
Le Coz CJ
Ann Dermatol Venereol; 1997; 124(4):351-9. PubMed ID: 9739947
[No Abstract] [Full Text] [Related]
14. [Possible treatment with immune system modulators of patients with pathology of the digestive organs. Informational letter].
Parfenov AI; Zvenogorodskaia LA; Il'chenko LIu; Ruchkina IN; Nazarenko IV
Eksp Klin Gastroenterol; 2003; (4):73-4. PubMed ID: 14653243
[No Abstract] [Full Text] [Related]
15. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae.
Appelbaum PC
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S29-34. PubMed ID: 10984325
[TBL] [Abstract][Full Text] [Related]
16. [Effect of Cerebral on the immune system in experimental hemorrhagic stroke].
Arkad'ev VG; Novik LV; Pustovarov AIu; Maksimov IuN; Makarenko AN
Eksp Klin Farmakol; 2002; 65(2):20-3. PubMed ID: 12109285
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents.
Labro MT
Expert Rev Anti Infect Ther; 2012 Mar; 10(3):319-40. PubMed ID: 22397566
[TBL] [Abstract][Full Text] [Related]
18. [Which partner for the betalactam agent in empiric combined therapy? I Fluoroquinolone].
Bedos JP
Ann Fr Anesth Reanim; 2004 Jun; 23(6):636-8. PubMed ID: 15234734
[No Abstract] [Full Text] [Related]
19. Fluoroquinolone and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug-resistant isolates.
Pérez-Trallero E; Marimon JM; Iglesias L; Larruskain J
Emerg Infect Dis; 2003 Sep; 9(9):1159-62. PubMed ID: 14519256
[TBL] [Abstract][Full Text] [Related]
20. [Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones].
Tomioka H; Sato K; Saito H
Kekkaku; 1996 Sep; 71(9):531-5. PubMed ID: 8999135
[No Abstract] [Full Text] [Related]
[Next] [New Search]
